全文获取类型
收费全文 | 20360篇 |
免费 | 1573篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 131篇 |
儿科学 | 746篇 |
妇产科学 | 583篇 |
基础医学 | 2546篇 |
口腔科学 | 257篇 |
临床医学 | 3085篇 |
内科学 | 3617篇 |
皮肤病学 | 186篇 |
神经病学 | 1610篇 |
特种医学 | 385篇 |
外国民族医学 | 1篇 |
外科学 | 2200篇 |
综合类 | 715篇 |
一般理论 | 39篇 |
预防医学 | 2766篇 |
眼科学 | 331篇 |
药学 | 1114篇 |
中国医学 | 15篇 |
肿瘤学 | 1642篇 |
出版年
2023年 | 88篇 |
2022年 | 113篇 |
2021年 | 353篇 |
2020年 | 238篇 |
2019年 | 361篇 |
2018年 | 367篇 |
2017年 | 266篇 |
2016年 | 365篇 |
2015年 | 427篇 |
2014年 | 557篇 |
2013年 | 875篇 |
2012年 | 1294篇 |
2011年 | 1375篇 |
2010年 | 664篇 |
2009年 | 624篇 |
2008年 | 1182篇 |
2007年 | 1313篇 |
2006年 | 1249篇 |
2005年 | 1272篇 |
2004年 | 1287篇 |
2003年 | 1218篇 |
2002年 | 1141篇 |
2001年 | 270篇 |
2000年 | 248篇 |
1999年 | 253篇 |
1998年 | 250篇 |
1997年 | 232篇 |
1996年 | 230篇 |
1995年 | 220篇 |
1994年 | 172篇 |
1993年 | 164篇 |
1992年 | 218篇 |
1991年 | 215篇 |
1990年 | 222篇 |
1989年 | 212篇 |
1988年 | 185篇 |
1987年 | 145篇 |
1986年 | 160篇 |
1985年 | 146篇 |
1984年 | 150篇 |
1983年 | 148篇 |
1982年 | 118篇 |
1981年 | 124篇 |
1980年 | 119篇 |
1979年 | 134篇 |
1978年 | 93篇 |
1977年 | 106篇 |
1976年 | 95篇 |
1974年 | 93篇 |
1972年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 562 毫秒
1.
2.
Christian Holm Hansen Shelley Lees Saidi Kapiga Janet Seeley Tony Barnett 《Global public health》2020,15(3):402-413
ABSTRACTMeasuring hope reliably and accurately remains an important research objective, not least in less prosperous settings where ‘holding on to hope’ may be critically important in the struggle against adverse life conditions. The State Hope Scale was designed for use in the US. Despite reported application in diverse cultures and using translations the scale has not been extensively validated outside US populations. This study contributes to a larger project exploring the measurement of hope and provides a critique of Snyder’s scale as used in a Tanzanian female population of 1021 urban microfinance participants. We evaluate the scale’s validity through assessment of the empirical distribution of scores, item response profiles, internal consistency and discriminatory ability. Participants mostly scored very high and many reached very near the maximum attainable score. Hardly any endorsed the negative half of the response scale. Several problems are discussed including poor discrimination and strong evidence of acquiescence response bias. We also found little association of the scale scores with hypothesised correlates of hope. Future improvements on the measurement of hope are recommended, especially in studies outside the narrow Western context in which the scale was devised. 相似文献
3.
ABSTRACTThis work collates data from the analysis of complex mixtures analysed in STRmix during routine no-suspect volume crime work. It interrogates the upload rate for these types of mixtures and which component of the profile has been able to be interpreted for upload. The number of profiles giving multiple uploads and the amount of replicate PCR analysis has been collated. 相似文献
4.
5.
Accurate diagnosis and recognition of predisposing factors has been shown to be challenging in lower limb cellulitis (LLC). Assessment of 1746 consecutive patients with cellulitis presenting to a UK university hospital showed increasing overdiagnosis, with only 31.9% of patients referred during the period 2015–2018 having the diagnosis of LLC confirmed. Recognition of at least one predisposing factor increased from 61% to 89% following introduction of more specific screening questions. This identified a need for better primary care dermatology education and the benefit of a proforma with specific screening questions for reversible predisposing factors for LLC. 相似文献
6.
7.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献8.
9.
Irritable bowel syndrome and health-related quality of life: a population-based study in Calgary, Alberta. 总被引:3,自引:0,他引:3
Feng Xiao Li Scott B Patten Robert J Hilsden Lloyd R Sutherland 《Journal canadien de gastroenterologie》2003,17(4):259-263
BACKGROUND: Little is known about the health-related quality of life (HRQOL) of nonclinical samples of people with irritable bowel syndrome (IBS) in Canada. In a pilot survey, the impact of IBS on HRQOL using a population-based, urban sample was examined. METHODS: A random sample of Calgary residents (18 years of age or older), selected by random digit dialing (n=1521), completed a structured questionnaire including ROME II Criteria and Medical Outcomes Study Short-Form 12-Item Health Survey, version 2 (SF-12v2). The mean scale and summary scores of SF-12v2 for those who did and did not meet ROME II criteria and for those who met ROME II criteria with and without visiting a physician in past three months were determined and compared using multiple regression analyses. RESULTS: Of the 951 households successfully contacted, 590 (62%) were willing to participate, of which 437 (74%) individuals were recruited. One hundred ten IBS cases (81 of which were women) and 327 non-IBS controls (180 of which were women) were identified. All of the eight mean scale scores and the two mean summary scores were significantly lower in people with IBS than in those without, whether or not adjusting for demographics. Forty-four of the 110 IBS cases (40%) sought medical help. Significantly lower mean physical component score and three scale scores (general health, social functioning and role physical) were found in those who sought medical help than in those who did not. CONCLUSIONS: People with IBS experience significant impairment in HRQOL, including both physical and mental well-being. People with IBS who seek medical help report worse physical health than those who do not, but their mental health is no different. 相似文献
10.